内分泌ペプチド検査の世界市場レポート 2025年

内分泌ペプチド検査市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.3％で142億2,000万米ドルに成長します。予測期間の成長は、内分泌ペプチド検査需要の増加、研究開発活動の成長、生活習慣病の増加、老人人口の増加、大衆の間での糖尿病有病率の上昇に起因しています。予測期間における主な動向としては、内分泌検査法の進歩、製品技術の進歩、新規検査ソリューション開発のための研究開発活動の活発化、製品承認数の増加、予防ヘルスケアへのシフトなどが挙げられます。

糖尿病の有病率の増加は、内分泌ペプチド検査市場の拡大を促進すると予想されます。糖尿病は、血糖値（グルコース）の上昇を特徴とするさまざまな病態を指します。糖尿病患者の増加は、食生活の乱れ、座りがちなライフスタイル、遺伝的要因、高齢化などの要因に起因しています。ヘモグロビンA1c、空腹時血糖、Cペプチド検査を含む内分泌ペプチド検査は、糖尿病の診断、グルコースレベルのモニター、インスリン産生と感受性の評価に使用されます。例えば、2024年6月、英国の政府機関である国民保健サービス（NHS）は、糖尿病と診断された40歳未満の個人の数が顕著に増加し、2022年の17万3,166人から2023年には21万6,440人に増加したと報告しました。この大幅な増加は、若年層における糖尿病患者の増加という懸念すべき動向を浮き彫りにしています。したがって、糖尿病の有病率の増加が内分泌ペプチド検査市場の成長を促進しています。

内分泌ペプチド検査市場の主要企業は、精度、感度、スピードを高めるために免疫測定検査システムの開発を進めています。これらのシステムは、抗体を用いて血液や尿サンプル中の特定のペプチドを検出・定量し、ヘルスケア専門家にホルモンレベルや内分泌機能に関する重要な洞察を提供します。例えば、シーメンス・ヘルティニアーズ社は、2023年7月に、内分泌ペプチドアッセイを含む免疫測定および臨床化学検査が可能なコンパクトなシステムであるAtellica CI Analyzerを発表しました。卵巣予備能評価のための抗ミュラーホルモン（AMH）や子癇前症の予後のためのsFlt-1やPlGFなどの検査が可能な生殖内分泌学メニューが特徴です。1時間当たり最大1,000件の検査が可能なAtellica CI Analyzerは、迅速かつ一貫した高品質の結果を提供し、検査室が変化する検査需要に対応できるようサポートします。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界内分泌ペプチド検査PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の内分泌ペプチド検査市場：成長率分析
• 世界の内分泌ペプチド検査市場の実績：規模と成長, 2019-2024
• 世界の内分泌ペプチド検査市場の予測：規模と成長, 2024-2029, 2034F
• 世界内分泌ペプチド検査総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の内分泌ペプチド検査市場テストタイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• デヒドロエピアンドロステロン硫酸塩
• プロゲステロン
• 黄体形成ホルモン
• 甲状腺プロラクチン
• エストラジオール
• ヒト絨毛性ゴナドトロピン
• 甲状腺刺激ホルモン
• その他のテストの種類
• 世界の内分泌ペプチド検査市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 質量分析
• 免疫測定
• クロマトグラフィー
• 核酸ベース
• その他のテクノロジー
• 世界の内分泌ペプチド検査市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• クリニック
• ヘルスケアセンター
• 病院
• 商業研究所
• 世界の内分泌ペプチド検査市場デヒドロエピアンドロステロン硫酸塩（DHEA-S）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 免疫測定検査
• 酵素免疫測定（ELISA）
• ラジオイムノアッセイ（RIA）
• 世界の内分泌ペプチド検査市場プロゲステロンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 免疫測定検査
• 化学発光アッセイ
• ELISA検査
• 世界の内分泌ペプチド検査市場黄体形成ホルモン（LH）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 免疫測定検査
• 酵素免疫測定（EIA）
• ラジオイムノアッセイ（RIA）
• 世界の内分泌ペプチド検査市場甲状腺プロラクチンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 免疫測定検査
• 化学発光アッセイ
• ラジオイムノアッセイ（RIA）
• 世界の内分泌ペプチド検査市場エストラジオールの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 免疫測定検査
• 酵素免疫測定（ELISA）
• ラジオイムノアッセイ（RIA）
• 世界の内分泌ペプチド検査市場ヒト絨毛性ゴナドトロピン（hCG）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 免疫測定検査
• 化学発光アッセイ
• 酵素免疫測定（EIA）
• 世界の内分泌ペプチド検査市場甲状腺刺激ホルモン（TSH）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 免疫測定検査
• ラジオイムノアッセイ（RIA）
• 酵素免疫測定（ELISA）
• 世界の内分泌ペプチド検査市場、その他のテストタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• コルチゾール
• インスリン
• 成長ホルモン（GH）
• 副甲状腺ホルモン（PTH）

第7章 地域別・国別分析

• 世界の内分泌ペプチド検査市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の内分泌ペプチド検査市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 内分泌ペプチド検査市場：競合情勢
• 内分泌ペプチド検査市場：企業プロファイル
  • Siemens AG Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Laboratory Corporation of America Holdings（LabCorp）
• Quest Diagnostics Incorporated
• Agilent Technologies Inc.
• Illumina Inc.
• bioMerieux SA
• Bio-Rad Laboratories Inc.
• DiaSorin S.p.A.
• Sciex
• Bio-Techne Corporation
• Invitae Corporation
• ARUP Laboratories
• Genova Diagnostics
• Boston Heart Diagnostics Corporation
• Immunodiagnostic Systems Ltd.
• Mayo Clinic Laboratories

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 内分泌ペプチド検査市場2029：新たな機会を提供する国
• 内分泌ペプチド検査市場2029：新たな機会を提供するセグメント
• 内分泌ペプチド検査市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

The endocrine peptide test is a diagnostic procedure used to assess levels of specific peptides in blood or urine, crucial for monitoring the endocrine system's function and detecting related disorders. It primarily focuses on measuring peptide hormones in blood to diagnose and track endocrine disorders.

Key tests in the endocrine peptide market include dehydroepiandrosterone sulfate (DHEAS), progesterone, luteinizing hormone, thyroid prolactin, estradiol, human chorionic gonadotropin, thyroid-stimulating hormone, among others. The DHEAS test specifically measures DHEAS levels in the bloodstream. Technologies employed include mass spectroscopy, immunoassay, chromatography, nucleic acid-based methods, and others. End users include clinics, healthcare centers, hospitals, and commercial laboratories.

The endocrine peptide test market research report is one of a series of new reports from The Business Research Company that provides endocrine peptide test market statistics, including the endocrine peptide test industry global market size, regional shares, competitors with endocrine peptide test market share, detailed endocrine peptide test market segments, market trends, and opportunities, and any further data you may need to thrive in the endocrine peptide test industry. These endocrine peptide test market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The endocrine peptide test market size has grown strongly in recent years. It will grow from $9.11 billion in 2024 to $9.97 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to increasing government spending, rising prevalence of diabetes, decreasing level of immunity in people across the world, high risk of contracting any chronic diseases, and rising government initiatives.

The endocrine peptide test market size is expected to see strong growth in the next few years. It will grow to $14.22 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to increasing demand for endocrine peptide test, growth in research and development activities, rise in number of lifestyle diseases, increasing geriatric population, and rising prevalence of diabetes amongst the masses. Major trends in the forecast period include advancement in the endocrine testing method, advancements in product technologies, increasing research and development activities to develop novel testing solutions, growing number of product approval, and shift towards preventive healthcare.

The growing prevalence of diabetes is expected to drive the expansion of the endocrine peptide test market. Diabetes refers to a range of conditions characterized by elevated blood sugar (glucose) levels. The rise in diabetes cases is attributed to factors such as poor diets, sedentary lifestyles, genetic factors, and an aging population. Endocrine peptide tests, including hemoglobin A1c, fasting plasma glucose, and C-peptide tests, are used to diagnose diabetes, monitor glucose levels, and evaluate insulin production and sensitivity. For example, in June 2024, the National Health Service (NHS), a UK-based government agency, reported a notable increase in the number of individuals under 40 diagnosed with diabetes, rising from 173,166 in 2022 to 216,440 in 2023. This significant increase highlights the concerning trend of rising diabetes cases among younger individuals. Therefore, the increasing prevalence of diabetes is fueling the growth of the endocrine peptide test market.

Leading companies in the endocrine peptide test market are advancing immunoassay testing systems to enhance accuracy, sensitivity, and speed. These systems employ antibodies to detect and quantify specific peptides in blood or urine samples, providing healthcare professionals with essential insights into hormone levels and endocrine function. For example, Siemens Healthineers introduced the Atellica CI Analyzer in July 2023, a compact system capable of immunoassay and clinical chemistry testing, including endocrine peptide assays. It features a reproductive endocrinology menu with tests such as anti-Mullerian hormone (AMH) for ovarian reserve assessment and sFlt-1 and PlGF for preeclampsia prognosis. With a capacity of up to 1000 tests per hour, the Atellica CI Analyzer ensures rapid and consistent delivery of high-quality results, supporting laboratories in meeting evolving testing demands.

In October 2022, Tolmar, a US-based pharmaceutical company, acquired Jatenzo from Clarus Therapeutics to bolster its portfolio in pediatric endocrinology and men's health. Jatenzo, a testosterone replacement therapy, complements Tolmar's specialty pharmaceutical products, enhancing their offerings for individuals with endocrine disorders. Clarus Therapeutics, known for developing therapies in this field, facilitated the acquisition, expanding Tolmar's market presence and therapeutic capabilities.

Major companies operating in the endocrine peptide test market are Siemens AG, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., bioMerieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Sciex, Bio-Techne Corporation, Invitae Corporation, ARUP Laboratories, Genova Diagnostics, Boston Heart Diagnostics Corporation, Immunodiagnostic Systems Ltd., Mayo Clinic Laboratories

North America was the largest region in the endocrine peptide test market in 2024. The regions covered in the endocrine peptide test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the endocrine peptide test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The endocrine peptide test market includes revenues earned by entities by providing services such as diagnostic testing, laboratory analysis, research studies, and clinical evaluations. The market value includes the value of related goods sold by the service provider or included within the service offering. The endocrine peptide test market also includes sales of diagnostic kits, reagents, testing instruments, and laboratory equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Endocrine Peptide Test Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on endocrine peptide test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for endocrine peptide test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The endocrine peptide test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Test-Type: Dehydroepiandrosterone Sulphate; Progesterone; Luteinizing Hormone; Thyroid Prolactin; Oestradiol; Human Chorionic Gonadotropin; Thyroid-Stimulating Hormone; Other Test-Types
• 2) By Technology: Mass Spectroscopy; Immunoassay; Chromatography; Nucleic Acid Based; Other Technologies
• 3) By End-User: Clinics; Healthcare Centers; Hospitals; Commercial Laboratories
• Subsegments:
• 1) By Dehydroepiandrosterone Sulphate (DHEA-S): Immunoassay Tests; Enzyme-Linked Immunosorbent Assay (ELISA); Radioimmunoassay (RIA)
• 2) By Progesterone: Immunoassay Tests; Chemiluminescence Assays; ELISA Tests
• 3) By Luteinizing Hormone (LH): Immunoassay Tests; Enzyme Immunoassay (EIA); Radioimmunoassay (RIA)
• 4) By Thyroid Prolactin: Immunoassay Tests; Chemiluminescence Assays; Radioimmunoassay (RIA)
• 5) By Oestradiol: Immunoassay Tests; Enzyme-Linked Immunosorbent Assay (ELISA); Radioimmunoassay (RIA)
• 6) By Human Chorionic Gonadotropin (hCG): Immunoassay Tests; Chemiluminescence Assays; Enzyme Immunoassay (EIA)
• 7) By Thyroid-Stimulating Hormone (TSH): Immunoassay Tests; Radioimmunoassay (RIA); Enzyme-Linked Immunosorbent Assay (ELISA)
• 8) Other Test-Types: Cortisol; Insulin; Growth Hormone (GH); Parathyroid Hormone (PTH)
• Companies Mentioned: Siemens AG; F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Merck KGaA; Becton Dickinson and Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Endocrine Peptide Test Market Characteristics

3. Endocrine Peptide Test Market Trends And Strategies

4. Endocrine Peptide Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Endocrine Peptide Test Growth Analysis And Strategic Analysis Framework

• 5.1. Global Endocrine Peptide Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Endocrine Peptide Test Market Growth Rate Analysis
• 5.4. Global Endocrine Peptide Test Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Endocrine Peptide Test Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Endocrine Peptide Test Total Addressable Market (TAM)

6. Endocrine Peptide Test Market Segmentation

• 6.1. Global Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dehydroepiandrosterone Sulphate
• Progesterone
• Luteinizing Hormone
• Thyroid Prolactin
• Oestradiol
• Human Chorionic Gonadotropin
• Thyroid-Stimulating Hormone
• Other Test-Types
• 6.2. Global Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mass Spectroscopy
• Immunoassay
• Chromatography
• Nucleic Acid Based
• Other Technologies
• 6.3. Global Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinics
• Healthcare Centers
• Hospitals
• Commercial Laboratories
• 6.4. Global Endocrine Peptide Test Market, Sub-Segmentation Of Dehydroepiandrosterone Sulphate (DHEA-S), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunoassay Tests
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Radioimmunoassay (RIA)
• 6.5. Global Endocrine Peptide Test Market, Sub-Segmentation Of Progesterone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunoassay Tests
• Chemiluminescence Assays
• ELISA Tests
• 6.6. Global Endocrine Peptide Test Market, Sub-Segmentation Of Luteinizing Hormone (LH), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunoassay Tests
• Enzyme Immunoassay (EIA)
• Radioimmunoassay (RIA)
• 6.7. Global Endocrine Peptide Test Market, Sub-Segmentation Of Thyroid Prolactin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunoassay Tests
• Chemiluminescence Assays
• Radioimmunoassay (RIA)
• 6.8. Global Endocrine Peptide Test Market, Sub-Segmentation Of Oestradiol, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunoassay Tests
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Radioimmunoassay (RIA)
• 6.9. Global Endocrine Peptide Test Market, Sub-Segmentation Of Human Chorionic Gonadotropin (hCG), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunoassay Tests
• Chemiluminescence Assays
• Enzyme Immunoassay (EIA)
• 6.10. Global Endocrine Peptide Test Market, Sub-Segmentation Of Thyroid-Stimulating Hormone (TSH), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunoassay Tests
• Radioimmunoassay (RIA)
• Enzyme-Linked Immunosorbent Assay (ELISA)
• 6.11. Global Endocrine Peptide Test Market, Sub-Segmentation Of Other Test-Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cortisol
• Insulin
• Growth Hormone (GH)
• Parathyroid Hormone (PTH)

7. Endocrine Peptide Test Market Regional And Country Analysis

• 7.1. Global Endocrine Peptide Test Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Endocrine Peptide Test Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Endocrine Peptide Test Market

• 8.1. Asia-Pacific Endocrine Peptide Test Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Endocrine Peptide Test Market

• 9.1. China Endocrine Peptide Test Market Overview
• 9.2. China Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Endocrine Peptide Test Market

• 10.1. India Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Endocrine Peptide Test Market

• 11.1. Japan Endocrine Peptide Test Market Overview
• 11.2. Japan Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Endocrine Peptide Test Market

• 12.1. Australia Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Endocrine Peptide Test Market

• 13.1. Indonesia Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Endocrine Peptide Test Market

• 14.1. South Korea Endocrine Peptide Test Market Overview
• 14.2. South Korea Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Endocrine Peptide Test Market

• 15.1. Western Europe Endocrine Peptide Test Market Overview
• 15.2. Western Europe Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Endocrine Peptide Test Market

• 16.1. UK Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Endocrine Peptide Test Market

• 17.1. Germany Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Endocrine Peptide Test Market

• 18.1. France Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Endocrine Peptide Test Market

• 19.1. Italy Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Endocrine Peptide Test Market

• 20.1. Spain Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Endocrine Peptide Test Market

• 21.1. Eastern Europe Endocrine Peptide Test Market Overview
• 21.2. Eastern Europe Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Endocrine Peptide Test Market

• 22.1. Russia Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Endocrine Peptide Test Market

• 23.1. North America Endocrine Peptide Test Market Overview
• 23.2. North America Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Endocrine Peptide Test Market

• 24.1. USA Endocrine Peptide Test Market Overview
• 24.2. USA Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Endocrine Peptide Test Market

• 25.1. Canada Endocrine Peptide Test Market Overview
• 25.2. Canada Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Endocrine Peptide Test Market

• 26.1. South America Endocrine Peptide Test Market Overview
• 26.2. South America Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Endocrine Peptide Test Market

• 27.1. Brazil Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Endocrine Peptide Test Market

• 28.1. Middle East Endocrine Peptide Test Market Overview
• 28.2. Middle East Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Endocrine Peptide Test Market

• 29.1. Africa Endocrine Peptide Test Market Overview
• 29.2. Africa Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Endocrine Peptide Test Market Competitive Landscape And Company Profiles

• 30.1. Endocrine Peptide Test Market Competitive Landscape
• 30.2. Endocrine Peptide Test Market Company Profiles
  • 30.2.1. Siemens AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Endocrine Peptide Test Market Other Major And Innovative Companies

• 31.1. Laboratory Corporation of America Holdings (LabCorp)
• 31.2. Quest Diagnostics Incorporated
• 31.3. Agilent Technologies Inc.
• 31.4. Illumina Inc.
• 31.5. bioMerieux SA
• 31.6. Bio-Rad Laboratories Inc.
• 31.7. DiaSorin S.p.A.
• 31.8. Sciex
• 31.9. Bio-Techne Corporation
• 31.10. Invitae Corporation
• 31.11. ARUP Laboratories
• 31.12. Genova Diagnostics
• 31.13. Boston Heart Diagnostics Corporation
• 31.14. Immunodiagnostic Systems Ltd.
• 31.15. Mayo Clinic Laboratories

32. Global Endocrine Peptide Test Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Endocrine Peptide Test Market

34. Recent Developments In The Endocrine Peptide Test Market

35. Endocrine Peptide Test Market High Potential Countries, Segments and Strategies

• 35.1 Endocrine Peptide Test Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Endocrine Peptide Test Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Endocrine Peptide Test Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer